» Articles » PMID: 16292055

Risk Factors for Acute Renal Failure: Inherent and Modifiable Risks

Overview
Specialty Critical Care
Date 2005 Nov 18
PMID 16292055
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Our purpose is to discuss established risk factors in the development of acute renal failure and briefly overview clinical markers and preventive measures.

Recent Findings: Findings from the literature support the role of older age, diabetes, underlying renal insufficiency, and heart failure as predisposing factors for acute renal failure. Diabetics with baseline renal insufficiency represent the highest risk subgroup. An association between sepsis, hypovolemia, and acute renal failure is clear. Liver failure, rhabdomyolysis, and open-heart surgery (especially valve replacement) are clinical conditions potentially leading to acute renal failure. Increasing evidence shows that intraabdominal hypertension may contribute to the development of acute renal failure. Radiocontrast and antimicrobial agents are the most common causes of nephrotoxic acute renal failure. In terms of prevention, avoiding nephrotoxins when possible is certainly desirable; fluid therapy is an effective prevention measure in certain clinical circumstances. Supporting cardiac output, mean arterial pressure, and renal perfusion pressure are indicated to reduce the risk for acute renal failure. Nonionic, isoosmolar intravenous contrast should be used in high-risk patients. Although urine output and serum creatinine lack sensitivity and specificity in acute renal failure, they remain the most used parameters in clinical practice.

Summary: There are identified risk factors of acute renal failure. Because acute renal failure is associated with a worsening outcome, particularly if occurring in critical illness and if severe enough to require renal replacement therapy, preventive measures should be part of appropriate management.

Citing Articles

Quantifying the potential contribution of drugs to the occurrence of acute kidney injury in patients with chronic kidney disease.

Laville S, Vendar J, Massy Z, Gras-Champel V, Moragny J, Frimat L Clin Kidney J. 2025; 18(1):sfae357.

PMID: 39781474 PMC: 11707387. DOI: 10.1093/ckj/sfae357.


Prevalence of renal insufficiency and factors associated among selected cancer patients on chemotherapy at Ocean Road Cancer Institute in Tanzania: a cross-sectional study.

Rajabu H, Hinderaker S, Mnandi P, Mutagonda R BMC Cancer. 2024; 24(1):763.

PMID: 38918707 PMC: 11201107. DOI: 10.1186/s12885-024-12419-y.


Urinary PART1 and PLA2R1 Could Potentially Serve as Diagnostic Markers for Diabetic Kidney Disease Patients.

Ye Q, Xu G, Yuan H, Mi J, Xie Y, Li H Diabetes Metab Syndr Obes. 2024; 16:4215-4231.

PMID: 38162802 PMC: 10757812. DOI: 10.2147/DMSO.S445341.


Detection, Monitoring, and Mitigation of Drug-Induced Nephrotoxicity: A Pragmatic Approach.

Antognini N, Portman R, Dong V, Webb N, Chand D Ther Innov Regul Sci. 2023; 58(2):286-302.

PMID: 38110788 PMC: 10850218. DOI: 10.1007/s43441-023-00599-x.


Outcomes of Upper Gastrointestinal Bleeding in Hospitalized Patients With Generalized Anxiety Disorder.

Kaye A, Baker B, Meyers S, Ahlawat S Cureus. 2022; 14(5):e25059.

PMID: 35719822 PMC: 9200930. DOI: 10.7759/cureus.25059.